Cargando…

Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines

Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Gündüz, Eren, Gülbaş, Zafer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986760/
https://www.ncbi.nlm.nih.gov/pubmed/24744617
http://dx.doi.org/10.5505/tjh.2012.10327
_version_ 1782311769385992192
author Gündüz, Eren
Gülbaş, Zafer
author_facet Gündüz, Eren
Gülbaş, Zafer
author_sort Gündüz, Eren
collection PubMed
description Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact patient quality of life. Additionally, there havebeen developments in supportive care, which seeks to ameliorate or minimize the negative effects of chemotherapy.Herein we present a review and brief summarization of some of the agents used for supportive care in cancer patientsin light of the latest guidelines.
format Online
Article
Text
id pubmed-3986760
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-39867602014-04-17 Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines Gündüz, Eren Gülbaş, Zafer Turk J Haematol Review Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact patient quality of life. Additionally, there havebeen developments in supportive care, which seeks to ameliorate or minimize the negative effects of chemotherapy.Herein we present a review and brief summarization of some of the agents used for supportive care in cancer patientsin light of the latest guidelines. Galenos Publishing 2012-03 2012-03-05 /pmc/articles/PMC3986760/ /pubmed/24744617 http://dx.doi.org/10.5505/tjh.2012.10327 Text en © Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Gündüz, Eren
Gülbaş, Zafer
Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines
title Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines
title_full Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines
title_fullStr Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines
title_full_unstemmed Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines
title_short Supportive Care in Hemato-Oncology: A Review in Light of the Latest Guidelines
title_sort supportive care in hemato-oncology: a review in light of the latest guidelines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986760/
https://www.ncbi.nlm.nih.gov/pubmed/24744617
http://dx.doi.org/10.5505/tjh.2012.10327
work_keys_str_mv AT gunduzeren supportivecareinhematooncologyareviewinlightofthelatestguidelines
AT gulbaszafer supportivecareinhematooncologyareviewinlightofthelatestguidelines